EA200401334A1 - Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением - Google Patents

Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением

Info

Publication number
EA200401334A1
EA200401334A1 EA200401334A EA200401334A EA200401334A1 EA 200401334 A1 EA200401334 A1 EA 200401334A1 EA 200401334 A EA200401334 A EA 200401334A EA 200401334 A EA200401334 A EA 200401334A EA 200401334 A1 EA200401334 A1 EA 200401334A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
levododopa
carbidope
controlled liberation
liberation
Prior art date
Application number
EA200401334A
Other languages
English (en)
Inventor
Мона Гогия
Раджив Шанкар Матхур
Санджив Сетхи
Original Assignee
Ранбакси Лабораторис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ранбакси Лабораторис Лимитед filed Critical Ранбакси Лабораторис Лимитед
Publication of EA200401334A1 publication Critical patent/EA200401334A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям карбидопы и леводопы с контролируемым высвобождением, содержащим сочетание простых эфиров целлюлозы, в частности гидроксипропилцеллюлозу, с разным молекулярным весом.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401334A 2002-04-11 2003-04-11 Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением EA200401334A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN447DE2002 2002-04-11
PCT/IB2003/001361 WO2003084514A1 (en) 2002-04-11 2003-04-11 Controlled release pharmaceutical compositions of carbidopa and levodopa

Publications (1)

Publication Number Publication Date
EA200401334A1 true EA200401334A1 (ru) 2005-04-28

Family

ID=28687123

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401334A EA200401334A1 (ru) 2002-04-11 2003-04-11 Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением

Country Status (7)

Country Link
US (1) US20060159751A1 (ru)
EP (1) EP1496868A1 (ru)
AU (1) AU2003214551A1 (ru)
BR (1) BR0309113A (ru)
EA (1) EA200401334A1 (ru)
MX (1) MXPA04009906A (ru)
WO (1) WO2003084514A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005946B1 (en) * 2006-04-12 2015-11-18 Nippon Soda Co., Ltd. Method for producing extended release tablet
JP4981036B2 (ja) * 2006-04-20 2012-07-18 伊藤ハム株式会社 コンフォメーション病医薬組成物
PL2432454T3 (pl) 2009-05-19 2017-10-31 Neuroderm Ltd Kompozycje do ciągłego podawania inhibitorów dopa-dekarboksylazy
PT2640358T (pt) 2010-11-15 2018-02-23 Neuroderm Ltd Administração contínua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos
NZ703341A (en) 2012-06-05 2016-11-25 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
DK3116475T3 (da) 2014-03-13 2020-12-07 Neuroderm Ltd Dopa-decarboxylasehæmmersammensætninger
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
WO2022044045A1 (en) * 2020-08-26 2022-03-03 Rubicon Research Private Limited Modified release formulations of levodopa
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424235A (en) * 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US6103263A (en) * 1994-11-17 2000-08-15 Andrx Pharmaceuticals, Inc. Delayed pulse release hydrogel matrix tablet
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa

Also Published As

Publication number Publication date
US20060159751A1 (en) 2006-07-20
WO2003084514A1 (en) 2003-10-16
BR0309113A (pt) 2005-02-01
AU2003214551A1 (en) 2003-10-20
EP1496868A1 (en) 2005-01-19
MXPA04009906A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
CY1109996T1 (el) Ανοσογονικη συνθεση
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
EA201000491A1 (ru) Аминометилзамещенные тетрациклиновые соединения
EA200401334A1 (ru) Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением
UY27346A1 (es) Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco.
SV2004001473A (es) Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo ref.pc 23132
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
TR201909741T4 (tr) Kolon temizleme bileşimleri.
ATE485331T1 (de) Thiolselektive wasserlösliche polymerderivate
NO20062508L (no) Administrering av levodopa og karbidopa
TR201908551T4 (tr) Yakıt bileşimleri.
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
EA200500074A1 (ru) Пленочное покрытие для таблеток и каплет
EA200300178A1 (ru) Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
NO20072699L (no) Leppefremhevelsessammensetning
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
EA200601759A1 (ru) Композиции рамиприла